A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD

Status:
Completed

Trial end date:
2005-12-01

Target enrollment:

Participant gender:

A randomised, controlled study investigating the effect of UK-369,003 on exercise tolerance in patients with COPD

Phase 1/Phase 2

Pfizer